Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice

SADIÇ, Beste Özben; Durakoglugil, Murtaza Emre; Gülbahar, Özlem; okyay, kaan; Karabay, Can Yucel; ERYÜKSEL, Semiha Emel; TEKİN, Abdullah; ŞAHİNARSLAN, Asife

doi:10.14744/AnatolJCardiol.2019.42247

Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice

Kaan OKYAY, (Başkent Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara, Türkiye)

Beste Özben SADIÇ, (Marmara Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İstanbul, Türkiye)

Asife ŞAHİNARSLAN, (Gazi Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara, Türkiye)

Murtaza Emre DURAKOĞLUGİL, (Recep Tayyip Erdoğan Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Rize, Türkiye)

Can Yücel KARABAY, (Siyami Ersek Göğüs Kalp Damar Cerrahisi Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, İstanbul, Türkiye)

Semiha Emel ERYÜKSEL, (Marmara Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları ve Yoğun Bakım Anabilim Dalı, İstanbul, Türkiye)

Özlem GÜLBAHAR, (Gazi Üniversitesi, Tıp Fakültesi, Biyokimya Anabilim Dalı, Ankara, Türkiye)

Abdullah TEKİN (Başkent Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Adana, Türkiye)

The Anatolian Journal of Cardiology

7 2

Yıl: 2019 Cilt: 21 Sayı: 6 Sayfa Aralığı: 331 - 344 Metin Dili: İngilizce DOI: 10.14744/AnatolJCardiol.2019.42247 İndeks Tarihi: 17-06-2020

Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice

Öz:

Cardiac troponins (cTn T and I) are protein molecules that are part of the contractile apparatus of the cardiac muscle. Increase in these biomarkers represents injury of myocardial cells without giving any evidence for the underlying mechanism (1, 2).

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık

1. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012; 60: 2427-63.
2. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al.; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018; 72: 2231-64.
3. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267-315.
4. Jaffe AS. Troponin-past, present, and future. Curr Probl Cardiol 2012; 37: 209-28.
5. Okyay K, Yıldırır A. The preanalytical and analytical factors responsible for false-positive cardiac troponins. Anatol J Cardiol 2015; 15: 264-5.
6. Tiwari RP, Jain A, Khan Z, Kohli V, Bharmal RN, Kartikeyan S, et al. Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction. Mol Diagn Ther 2012; 16: 371-81.
7. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al.; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010; 31: 2197-204.
8. Galli C, Lippi G. High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages. Ann Transl Med 2016; 4: 257.
9. Giannitsis E, Katus HA. Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol 2013; 10: 623-34.
10. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48: 1-11.
11. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 67: 1360-7.
12. Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem 2008; 45: 349-55.
13. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res 2017; 113: 1708-18.
14. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J; IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac Troponin Assays: Guide to Under-standing Analytical Characteristics and Their Impact on Clinical Care. Clin Chem 2017; 63: 73-81.
15. Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th Ed. Cardiac Function: Chapter 47. Elsevier; 2012. p.1457-522.
16. Jaffe AS, Morrow DA. Troponin testing: analytical considerations. Saperia GM, Ed. UpToDate. Waltham, MA. Accessed on February 13, 2019. Available from: URL: https://www.uptodate.com.
17. Pickering JW, Than MP, Cullen L, Aldous S, Ter Avest E, Body R, et al. Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. Ann Intern Med 2017; 166: 715-24.
18. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004; 25:105-20.
19. Herman DS, Kavsak PA, Greene DN. Variability and Error in Cardiac Troponin Testing: An ACLPS Critical Review. Am J Clin Pathol 2017; 148: 281-95.
20. Howanitz JH, Bjerner J, Chace NM, Cook BC, Datta P, Doss RC. CLSI. Immunoassay Interference by Endogenous Antibodies; Approved Guideline. CLSI document I/LA30-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
21. Herman DS, Ranjitkar P, Yamaguchi D, Grenache DG, Greene DN. Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification. Clin Biochem 2016; 49: 1118-21.
22. Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, et al. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab 2017; 122: 4-17.
23. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108: 833-8.
24. Nunes JP, Mota Garcia JM, Farinha RM, Carlos Silva J, Magalhães D, Vidal Pinheiro L, et al. Cardiac troponin I in aortic valve disease. Int J Cardiol 2003; 89: 281-5.
25. Logeart D, Beyne P, Cusson C, Tokmakova M, Leban M, Guiti C, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 2001; 141: 247-53.
26. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001; 103: 2035-7.
27. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96: 2247-59.
28. Fonarow GC, Horwich TB. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 2003; 4 (Suppl 4): S20-8.
29. Peacock WF 4th, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al.; ADHERE Investigators. Cardiac Troponin and Outcome in Acute Heart Failure. N Engl J Med 2008; 358: 2117-26.
30. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure: prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010; 56: 1071-8.
31. Patil H, Vaidya O, Bogart D. A review of causes and systemic approach to cardiac troponin elevation. Clin Cardiol 2011; 34: 723-8.
32. Krams R, Kofflard MJ, Duncker DJ, Von Birgelen C, Carlier S, Kliffen M, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998; 97: 230-3.
33. Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, et al. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Am Coll Cardiol 2013; 62: 1252-9.
34. Cantwell RV, Aviles RJ, Bjornsson J, Wright RS, Freeman WK, Oh JK, et al. Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol 2002; 25: 33-7.
35. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003; 361: 1787-9.
36. Baba Y, Kubo T, Kitaoka H, Okawa M, Yamanaka S, Kawada Y, et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J 2012; 53: 287-92.
37. Weil BR, Young RF, Shen X, Suzuki G, Qu J, Malhotra S, et al. Brief Myocardial Ischemia Produces Cardiac Troponin I Release and Focal Myocyte Apoptosis in the Absence of Pathological Infarction in Swine. JACC Basic Transl Sci 2017; 2: 105-14.
38. Hammarsten O, Mair J, Möckel M, Lindahl B, Jaffe AS. Possible mechanisms behind cardiac troponin elevations. Biomarkers 2018; 23: 725-34.
39. Cote GM, Sawyer DB, Chabner BA. ERBB2 inhibition and heart failure. N Engl J Med 2012; 367: 2150-3.
40. Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol 2005; 23: 2900-2.
41. Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamantia G, et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 2000; 36: 517-22.
42. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al.; ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2768-801.
43. Mauermann E, Bolliger D, Fassl J, Grapow M, Seeberger EE, Seeberger MD, et al. Association of Troponin Trends and Cardiac Morbidity and Mortality After On-Pump Cardiac Surgery. Ann Thorac Surg 2017; 104: 1289-97.
44. Chorianopoulos E, Krumsdorf U, Geis N, Pleger ST, Giannitsis E, Katus HA, et al. Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis. Clin Res Cardiol 2014; 103: 65-72.
45. Nikolaou NI, Christou AH, Spanodimos SG, Antonatos DG, Korkonikitas PI, Patsilinakos SP. Marked troponin elevation after implantation of a permanent antibradycardia pacemaker. Hellenic J Cardiol 2011; 52: 489-92.
46. Piechota W, Gielerak G, Ryczek R, Kaźmierczak A, Bejm J, Piechota W. Cardiac troponin I after external electrical cardioversion for atrial fibrillation as a marker of myocardial injury a preliminary report. Kardiol Pol 2007; 65: 664-9.
47. Miranda CH, Schmidt A, Pazin-Filho A. Prognostic evaluation of the troponin I elevation after multiple spontaneous shocks of the implantable cardioverter/defibrillator. Am J Emerg Med 2014; 32: 1085-8.
48. Reichlin T, Lockwood SJ, Conrad MJ, Nof E, Michaud GF, John RM, et al. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation. J Interv Card Electrophysiol 2016; 47: 69-74.
49. de Lamos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503-12.
50. Blankanberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, et al. Troponin I and cardiovascular risk prediction in the general population: the BiomarCARE consortium. Eur Heart J 2016; 37: 2428-37.
51. Januzzi JL Jr, Suchindran S, Hoffmann U, Patel MR, Ferencik M, Coles A, et al.; PROMISE Investigators. Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain. J Am Coll Cardiol 2019; 73: 251-60.
52. Body R. Acute coronary syndromes diagnosis, version 2.0: Tomorrow's approach to diagnosing acute coronary syndromes? Turk J Emerg Med 2018; 18: 94-9.
53. Cervellin G, Mattiuzzi C, Bovo C, Lippi G. Diagnostic algorithms for acute coronary syndrome-is one better than another? Ann Transl Med 2016; 4: 193.
54. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999; 354: 1757-62.
55. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L; FRISC II (Fast Revascularization during In Stability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001; 38: 979-86.
56. Pattanshetty DJ, Bhat PK, Aneja A, Pillai DP. Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis: a retrospective study. J Hypertens 2012; 30: 2410-5.
57. Pourafkari L, Tajlil A, Ghaffari S, Chavoshi M, Kolahdouzan K, Parvizi R, et al. Electrocardiography changes in acute aortic dissection-association with troponin leak, coronary anatomy, and prognosis. Am J Emerg Med 2016; 34: 1431-6.
58. Biagini E, Lofiego C, Ferlito M, Fattori R, Rocchi G, Graziosi M, et al. Frequency, determinants, and clinical relevance of acute coronary syndrome-like electrocardiographic findings in patients with acute aortic syndrome. Am J Cardiol 2007; 100: 1013-9.
59. Vagnarelli F, Corsini A, Bugani G, Lorenzini M, Longhi S, Bacchi Reggiani ML, et al. Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis. Eur Heart J Acute Cardiovasc Care 2016; 5: 61-71.
60. Li G, Wu XW, Lu WH, Cheng J, Wu XY, Ai R, et al. High-sensitivity cardiac troponin T: A biomarker for the early risk stratification of type-A acute aortic dissection? Arch Cardiovasc Dis 2016; 109: 163-70.
61. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015; 373: 929-38.
62. Ramaraj R, Sorrell VL, Movahed MR. Levels of troponin release can aid in the early exclusion of stress-induced (takotsubo) cardiomyopathy. Exp Clin Cardiol 2009; 14: 6-8.
63. Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol 2008; 101: 1723-8.
64. Song BG, Park SJ, Noh HJ, Jo HC, Choi JO, Lee SC, et al. Clinical characteristics, and laboratory and echocardiographic findings in takotsubo cardiomyopathy presenting as cardiogenic shock. J Crit Care 2010; 25: 329-35.
65. Gautam PL, Luthra N, Kaur M, Singh J, Wander GS, Tandon R, et al. Evaluation of Myocardial Injury using Standard Diagnostic Tools and Tissue Doppler Imaging in Blunt Trauma Chest. J Clin Diagn Res 2017; 11: OC33-6.
66. Sybrandy KC, Cramer MJ, Burgersdijk C. Diagnosing cardiac contusion: old wisdom and new insights. Heart 2003; 89: 485-9.
67. Kalbitz M, Pressmar J, Stecher J, Weber B, Weiss M, Schwarz S, et al. The Role of Troponin in Blunt Cardiac Injury After Multiple Trauma in Humans. World J Surg 2017; 41: 162-9.
68. RuDusky BM. More on myocardial contusion--with additional insight on myocardial concussion. Chest 1997; 112: 570-2.
69. Edouard AR, Benoist JF, Cosson C, Mimoz O, Legrand A, Samii K. Circulating cardiac troponin I in trauma patients without cardiac contusion. Intensive Care Med 1998; 24: 569-73.
70. Salim A, Hadjizacharia P, Brown C, Inaba K, Teixeira PG, Chan L, et al. Significance of troponin elevation after severe traumatic brain injury. J Trauma 2008; 64: 46-52.
71. Martin M, Mullenix P, Rhee P, Belzberg H, Demetriades D, Salim A. Troponin increases in the critically injured patient: mechanical trauma or physiologic stress? J Trauma 2005; 59: 1086-91.
72. Mahmood I, El-Menyar A, Dabdoob W, Abdulrahman Y, Siddiqui T, Atique S, et al. Troponin T in Patients with Traumatic Chest Injuries with and without Cardiac Involvement: Insights from an Observational Study. N Am J Med Sci 2016; 8: 17-24.
73. Fernando H, Adams N, Mitra B. Review article: The utility of troponin and other investigations in patients presenting to the emergency department with supraventricular tachycardia. Emerg Med Australas 2019; 31: 35-42.
74. Schueler M, Vafaie M, Becker R, Biener M, Thomas D, Mueller M, et al. Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia. Acute Card Care 2012; 14: 131-7.
75. Bukkapatnam RN, Robinson M, Turnipseed S, Tancredi D, Amsterdam E, Srivatsa UN. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol 2010; 106: 374-7.
76. Higgins JP, Higgins JA. Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med 2003; 26: 133-47.
77. Qi W, Kjekshus H, Klinge R, Kjekshus JK, Hall C. Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs. Acta Physiol Scand 2000; 169: 95-102.
78. Sayadnik M, Shafiee A, Jenab Y, Jalali A, Sadeghian S. Predictors of High-Sensitivity Cardiac Troponin T Elevation in Patients with Acute Paroxysmal Supraventricular Tachycardia and Ischemic Heart Disease. Tex Heart Inst J 2017; 44: 306-11.
79. Niederdöckl J, Simon A, Schnaubelt S, Schuetz N, Laggner R, Sulzgruber P, et al. Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation. Heart 2019; 105: 482-8.
80. Imazio M, Demichelis B, Cecchi E, Belli R, Ghisio A, Bobbio M, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 2003; 42: 2144-8.
81. Brandt RR, Filzmaier K, Hanrath P. Circulating cardiac troponin I in acute pericarditis. Am J Cardiol 2001; 87: 1326-8.
82. Bonnefoy E, Godon P, Kirkorian G, Fatemi M, Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 2000; 21: 832-6.
83. Gamaza-Chulián S, León-Jiménez J, Recuerda-Núñez M, Camacho-Freire S, Gutiérrez-Barrios A, Vargas-Machuca JC. Cardiac troponin-T in acute pericarditis. J Cardiovasc Med (Hagerstown) 2014; 15: 68-72.
84. Machado S, Roubille F, Gahide G, Vernhet-Kovacsik H, Cornillet L, Cung TT, et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris) 2010; 59: 1-7.
85. Imazio M, Brucato A, Barbieri A, Ferroni F, Maestroni S, Ligabue G, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation 2013; 128: 42-9.
86. Franz WM, Remppis A, Kandolf R, Kübler W, Katus HA. Serum troponin T: diagnostic marker for acute myocarditis. Clin Chem 1996; 42: 340-1.
87. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocardits. Experimental and clinical correlates. Circulation 1997; 95: 163-8.
88. Lauer B, Niederau C, Kühl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 1354-9.
89. Ukena C, Kindermann M, Mahfoud F, Geisel J, Lepper PM, Kandolf R, et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol 2014; 103: 743-51.
90. Al-Biltagi M, Issa M, Hagar HA, Abdel-Hafez M, Aziz NA. Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Paediatr 2010; 99: 1510-6.
91. Eckart RE, Shry EA, Jones SO 4th, Atwood JE, Grabenstein JD. Comparison of clinical presentation of acute myocarditis following smallpox vaccination to acute coronary syndromes in patients <40 years of age. Am J Cardiol 2005; 95: 1252-5.
92. Fan Y, Chen M, Liu M, Yang X. Myocarditis with chest pain, normal heart function and extreme increased troponin. Int J Cardiol 2016; 209: 307-9.
93. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, et al. Age- and-sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014; 63: 1441-8.
94. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011; 32: 1379-89.
95. Wu W, Li DX, Wang Q, Xu Y, Cui YJ. Relationship between highsensitivity cardiac troponin T and the prognosis of elderly in patients with non-acute coronary syndromes. Clin Interv Aging 2018; 13: 1091-8.
96. Rahman A, Broadley SA. Review article: elevated troponin: diagnostic gold orfool's gold? Emerg Med Australas 2014; 26: 125-30.
97. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-5.
98. Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J 2012; 33: 2265-71.
99. Dierkes J, Domröse U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102: 1964-9.
100. NACB Writing Group, Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53: 2086-96.
101. Torbicki A, Kurzyna M, Kuca P, Fijałkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108: 844-8.
102. Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, Kleber FX, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106: 319-24.
103. Regwan S, Hulten EA, Martinho S, Slim J, Villines TC, Mitchell J, et al. Marathon running as a cause of troponin elevation: a systematic review and meta-analysis. J Interv Cardiol 2010; 23: 443-50.
104. Vilela EM, Bastos JC, Rodrigues RP, Nunes JP. High-sensitivity troponin after running-a systematic review. Neth J Med 2014; 72: 5-9.
105. O'Hanlon R, Wilson M, Wage R, Smith G, Alpendurada FD, Wong J, et al. Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2010; 12: 38.
106. Siegel AJ, Sholar M, Yang J, Dhanak E, Lewandrowski KB. Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned? Cardiology 1997; 88: 487-91.
107. Samaha E, Avila A, Helwani MA, Ben Abdallah A, Jaffe AS, Scott MG, et al. High-Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2019; 8: e008626.
108. Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, et al.; POISE (Peri Operative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing non cardiac surgery: a cohort study. Ann Intern Med 2011; 154: 523-8.
109. Writing Committee for the VISION Study Investigators, Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, et al. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA 2017; 317: 1642-51.
110. Levy M, Heels-Ansdell D, Hiralal R, Bhandari M, Guyatt G, Yusuf S, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 2011; 114: 796-806.
111. Gunduz H, Arinc H, Yolcu M, Akdemir R, Kanat M, Uyan C. A case of hypothyroidism mimicking acute coronary syndrome. Int J Cardiovasc Imaging 2006; 22: 141-5.
112. Buschmann IR, Bondke A, Elgeti T, Kühnle Y, Dietz R, Möckel M. Positive cardiac troponin I and T and chest pain in a patient with iatrogenic hypothyroidism and no coronary artery disease. Int J Cardiol 2007; 115: e83-5.
113. Cohen LF, Mohabeer AJ, Keffer JH, Jialal I. Troponin I in hypothyroidism. Clin Chem 1996; 42: 1494-5.
114. Ness-Abramof R, Nabriski DA, Shapiro MS, Tripto-Shkolnik L, Katz B, Weiss E, et al. Cardiac troponin T is not increased in patients with hypothyroidism. Intern Med J 2009; 39: 117-20.
115. Ilva TJ, Eskola MJ, Nikus KC, Voipio-Pulkki LM, Lund J, Pulkki K, et al. The etiology and prognostic significance of cardiac troponin I elevation in unselected emergency department patients. J Emerg Med 2010; 38: 1-5.
116. Goldhaber SZ. Cardiac biomarkers in pulmonary embolism. Chest 2003; 123: 1782-4.
117. Giannitsis E, Müller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-7.
118. Jolobe OM. Troponin T elevation in lobar lung disease. Postgrad Med J 2002; 78: 443.
119. Müller-Bardorff M, Weidtmann B, Giannitsis E, Kurowski V, Katus HA. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem 2002; 48: 673-5.
120. Baillard C, Boussarsar M, Fosse JP, Girou E, Le Toumelin P, Cracco C, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003; 29: 584-9.
121. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med 2006; 166: 2446-54.
122. Papp A, Uusaro A, Parviainen I, Hartikainen J, Ruokonen E. Myocardial function and hemodynamics in extensive burn trauma: evaluation by clinical signs, invasive monitoring, echocardiography, and cytokine concentrations. A prospective clinical study. Acta Anaesthesiol Scand 2003; 47: 1257-63.
123. Bak Z, Sjöberg F, Eriksson O, Steinvall I, Janerot-Sjoberg B. Cardiac dysfunction after burns. Burns 2008; 34: 603-9.
124. Wang T, He W. The clinical significance of the dynamic change in serum cardiac troponin T in burned patients. Zhonghua Shao Shang Za Zhi 2000; 16: 147-9.
125. Kerr G, Ray G, Wu O. Stott DJ, Langhorne P. Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 2009; 28: 220-6.
126. Jensen JK, Kristensen SR, Bak S, Atar D, Høilund-Carlsen PF, Mickley H. Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 2007; 99: 108-12.
127. Faiz KW, Thommessen B, Einvik G, Brekke PH, Omland T, Rønning OM. Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke. BMC Neurol 2014; 14: 96.
128. Sato K, MasudaT, Izumi T. Subarachnoid hemorrhage and myocardial damage clinical and experimental studies. Jpn Heart J 1999; 40: 683-701.129. Gopinath R, Ayya SS. Neurogenic stress cardiomyopathy: What do we need to know. Ann Card Anaesth 2018; 21: 228-34.
130. Van Houten J, FrickerG, Collins B, Bhatia R, Ellis C, Schrag M. Circulating troponin I level in patients with acute ischemic stroke. Curr Neurol Neurosci Rep 2018; 18: 32.
131. Wrigley P, Khoury J, Eckerle B, Alwell K, Moomaw CJ, Woo D, et al. Prevalence of positive troponin and echocardiogram findings and association with mortality in acute ischemic stroke. Stroke 2017; 48: 1226-32.
132. Kotlyar S, Olupot-Olupot P, Nteziyarenye J, Akech SO, Uyoga S, Muhindo R, et al. Assessment of Myocardial Function and Injury by Echocardiography and Cardiac Biomarkers in African Children With Severe Plasmodium falciparum Malaria. Pediatr Crit Care Med 2018; 19: 179-85.
133. Sadoh WE, Uduebor JO. Electrocardiographic changes and Troponin T levels in children with severe malaria anemia and heart failure. Niger J Clin Prac 2017; 20: 552-6.
134. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-6.
135. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003; 107: 223-5.
136. Barbarova I, Klempfner R, Rapoport A, Wasserstrum Y, Goren I, Kats A, et al. Avoidance of Blood Transfusion to Patients Suffering From Myocardial Injury and Severe Anemia Is Associated With Increased Long-Term Mortality: A Retrospective Cohort Analysis. Medicine (Baltimore) 2015; 94: e1635.
137. Li SF, Zapata J, Tillem E. The prevelance of false-positive cardiac troponin I in ED patients with rhabdomyolysis. Am J Emerg Med 2005: 23: 860-3.
138. Rittoo D, Jones A, Lecky B, Neithercut D. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases. Implications for the diagnosis of myocardial infarction. J Am Coll Cardiol 2014; 63: 2411-20.
139. Messner B, Baum H, Fischer P, Quasthoff S, Neumeier D. Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. Am J Clin Pathol 2000; 114: 544-9.
140. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll of Cardiol 2011; 58: 1819-24.
141. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84: 209-38.
142. Sribhen K, Phankingthongkum R, Wannasilp N. Skeletal muscle disease as noncardiac cause of cardiac troponin T elevation. J Am Coll Cardiol 2012; 59: 1334-5.
143. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofolassociated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem 2000; 46: 577-81.

APA	okyay k, SADIÇ B, ŞAHİNARSLAN A, Durakoglugil M, Karabay C, ERYÜKSEL S, Gülbahar Ö, TEKİN A (2019). Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. , 331 - 344. 10.14744/AnatolJCardiol.2019.42247
Chicago	okyay kaan,SADIÇ Beste Özben,ŞAHİNARSLAN Asife,Durakoglugil Murtaza Emre,Karabay Can Yucel,ERYÜKSEL Semiha Emel,Gülbahar Özlem,TEKİN Abdullah Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. (2019): 331 - 344. 10.14744/AnatolJCardiol.2019.42247
MLA	okyay kaan,SADIÇ Beste Özben,ŞAHİNARSLAN Asife,Durakoglugil Murtaza Emre,Karabay Can Yucel,ERYÜKSEL Semiha Emel,Gülbahar Özlem,TEKİN Abdullah Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. , 2019, ss.331 - 344. 10.14744/AnatolJCardiol.2019.42247
AMA	okyay k,SADIÇ B,ŞAHİNARSLAN A,Durakoglugil M,Karabay C,ERYÜKSEL S,Gülbahar Ö,TEKİN A Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. . 2019; 331 - 344. 10.14744/AnatolJCardiol.2019.42247
Vancouver	okyay k,SADIÇ B,ŞAHİNARSLAN A,Durakoglugil M,Karabay C,ERYÜKSEL S,Gülbahar Ö,TEKİN A Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. . 2019; 331 - 344. 10.14744/AnatolJCardiol.2019.42247
IEEE	okyay k,SADIÇ B,ŞAHİNARSLAN A,Durakoglugil M,Karabay C,ERYÜKSEL S,Gülbahar Ö,TEKİN A "Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice." , ss.331 - 344, 2019. 10.14744/AnatolJCardiol.2019.42247
ISNAD	okyay, kaan vd. "Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice". (2019), 331-344. https://doi.org/10.14744/AnatolJCardiol.2019.42247

APA	okyay k, SADIÇ B, ŞAHİNARSLAN A, Durakoglugil M, Karabay C, ERYÜKSEL S, Gülbahar Ö, TEKİN A (2019). Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. The Anatolian Journal of Cardiology, 21(6), 331 - 344. 10.14744/AnatolJCardiol.2019.42247
Chicago	okyay kaan,SADIÇ Beste Özben,ŞAHİNARSLAN Asife,Durakoglugil Murtaza Emre,Karabay Can Yucel,ERYÜKSEL Semiha Emel,Gülbahar Özlem,TEKİN Abdullah Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. The Anatolian Journal of Cardiology 21, no.6 (2019): 331 - 344. 10.14744/AnatolJCardiol.2019.42247
MLA	okyay kaan,SADIÇ Beste Özben,ŞAHİNARSLAN Asife,Durakoglugil Murtaza Emre,Karabay Can Yucel,ERYÜKSEL Semiha Emel,Gülbahar Özlem,TEKİN Abdullah Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. The Anatolian Journal of Cardiology, vol.21, no.6, 2019, ss.331 - 344. 10.14744/AnatolJCardiol.2019.42247
AMA	okyay k,SADIÇ B,ŞAHİNARSLAN A,Durakoglugil M,Karabay C,ERYÜKSEL S,Gülbahar Ö,TEKİN A Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. The Anatolian Journal of Cardiology. 2019; 21(6): 331 - 344. 10.14744/AnatolJCardiol.2019.42247
Vancouver	okyay k,SADIÇ B,ŞAHİNARSLAN A,Durakoglugil M,Karabay C,ERYÜKSEL S,Gülbahar Ö,TEKİN A Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice. The Anatolian Journal of Cardiology. 2019; 21(6): 331 - 344. 10.14744/AnatolJCardiol.2019.42247
IEEE	okyay k,SADIÇ B,ŞAHİNARSLAN A,Durakoglugil M,Karabay C,ERYÜKSEL S,Gülbahar Ö,TEKİN A "Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice." The Anatolian Journal of Cardiology, 21, ss.331 - 344, 2019. 10.14744/AnatolJCardiol.2019.42247
ISNAD	okyay, kaan vd. "Turkish Society of Cardiology consensus report on the rational use of cardiac troponins in daily practice". The Anatolian Journal of Cardiology 21/6 (2019), 331-344. https://doi.org/10.14744/AnatolJCardiol.2019.42247